| 0.3155 0.03 (10.55%) | 01-30 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.58  |
1-year : | 0.75 |
| Resists | First : | 0.5 |
Second : | 0.64 |
| Pivot price | 0.37 |
|||
| Supports | First : | 0.26 |
Second : | 0.22 |
| MAs | MA(5) : | 0.31 |
MA(20) : | 0.39 |
| MA(100) : | 0.79 |
MA(250) : | 0.91 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 12.1 |
D(3) : | 9.3 |
| RSI | RSI(14): 28.5 |
|||
| 52-week | High : | 1.41 | Low : | 0.26 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ XWEL ] has closed above bottom band by 22.4%. Bollinger Bands are 25% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.43 - 0.43 | 0.43 - 0.44 |
| Low: | 0.26 - 0.26 | 0.26 - 0.27 |
| Close: | 0.31 - 0.32 | 0.32 - 0.32 |
XWELL Inc., a health and wellness services company, provides spa services at airports. It operates through XpresSpa, XpresTest, Treat, and HyperPointe brands. The company offers spa services, including massage, and nail and skin care, as well as spa and travel products; and retail products. It also operates wellness centers that provides COVID-19 screening and testing, and rapid testing services for other communicable diseases, such as influenza, COVID-19, RSV, Flu A&B, and seasonal flu vaccination services; and other medical diagnostic testing services. In addition, the company offers services through an integrated digital platform, and a relevant retail offering to the traveling public. As of December 31, 2021, it operated 52 spa and clinic locations in 24 airports in the United States, the Netherlands, and the United Arab Emirates. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL Inc. in October 2022. XWELL Inc. is headquartered in New York, New York.
Thu, 18 Dec 2025
XWELL Shareholders Approve Reverse Split, Capital Flexibility Moves - TipRanks
Fri, 14 Nov 2025
XWELL, Inc. Reports Third Quarter 2025 Results, Expands Global Partnership and Streamlines Operations - Quiver Quantitative
Thu, 09 Oct 2025
Xwell cancels annual shareholder meeting and withdraws proposals - Investing.com
Fri, 12 Sep 2025
XWELL Celebrates Grand Opening of New Wellness Center in Brandon, Florida - Quiver Quantitative
Mon, 11 Aug 2025
XWELL, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement | XWEL Stock News - Quiver Quantitative
Tue, 29 Jul 2025
XWELL Launches All-New Website, Offering Seamless Booking - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Consumer Cyclical
|
|
|
Industry:
Personal Products & Services
|
|
| Shares Out | 6 (M) |
| Shares Float | 4 (M) |
| Held by Insiders | 16.4 (%) |
| Held by Institutions | 14 (%) |
| Shares Short | 69 (K) |
| Shares Short P.Month | 72 (K) |
| EPS | -3.34 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -1.11 |
| Profit Margin | -51.9 % |
| Operating Margin | -3.9 % |
| Return on Assets (ttm) | -22.6 % |
| Return on Equity (ttm) | -159 % |
| Qtrly Rev. Growth | -12.9 % |
| Gross Profit (p.s.) | 0.98 |
| Sales Per Share | 5.11 |
| EBITDA (p.s.) | -1.6 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -12 (M) |
| Levered Free Cash Flow | -9 (M) |
| PE Ratio | -0.1 |
| PEG Ratio | 0 |
| Price to Book value | -0.29 |
| Price to Sales | 0.06 |
| Price to Cash Flow | -0.16 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|